Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |